Latest news with #IVC
Yahoo
6 days ago
- Business
- Yahoo
Mindset Medical Announces FDA Clearance for its Contactless Respiratory Rate Measurement Device
PHOENIX, June 4, 2025 /PRNewswire/ -- Mindset Medical, Inc. ("Mindset Medical" or the "Company"), a digital health company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest contactless vital sign monitoring solution. The Informed Vital Core (IVC) App is a software-only medical device that measures respiratory rate through smartphones, tablets, or laptop cameras. This milestone marks Mindset Medical's second FDA clearance in less than a year, building on the success of its previously cleared pulse rate measurement device on November 18, 2024. With these clearances, Mindset Medical is closer to transforming the delivery of care with innovative telehealth technology. Mindset Medical can now offer another solution for healthcare providers to gather physiological information from their patients without needing physical contact or dedicated hardware. Software on phones, tablets, and laptops can easily be deployed in clinical and outpatient facilities, remote care environments, long-term care settings, or the patient's home. Telemedicine skyrocketed due to COVID-19, as many barriers to adoption were removed, allowing video conferencing to become routine. "Video alone is not enough. Patients and providers deserve virtual services with fewer barriers and limitations because we are all patients at the end of the day. The next step is purpose-built virtual health offerings that can legitimately provide brick-and-mortar experiences. Virtual healthcare remains a permanent fixture moving forward, and we have only scratched the surface of how we use technology to address shortcomings with the health system."-- Mitch Foster, Chairman and CEO of Mindset Medical. Mindset Medical envisions a future where vital signs and diagnoses can be captured with nothing more than everyday devices. This will help bridge gaps in access to healthcare, reduce the burden on providers, and improve chances for earlier intervention. The company continues developing its platform to include additional vital sign measurements, working closely with clinicians and patients to ensure each new feature meets their needs. About Mindset Medical Mindset Medical, Inc. ( headquartered in Phoenix, AZ, was formed by several members of Excelsius Surgical, a robotic surgical platform. Recently, Mindset Medical has developed proprietary signal-processing algorithms that extract health measurements from video. Combined with AI technology for advanced image analysis and facial recognition, these algorithms transform patients' smartphones into contactless vital sign measurement devices. Mindset Medical utilizes secure and encrypted links delivered to patients from healthcare providers to collect up-to-the-minute patient data and accurate remote physiological measurements. Contact For media, sales, or investor inquiries, please email 396163@ or 396163@ We can also be reached at 480.269.0859. HASHTAGS#healthcare #telehealth #healthequity #vitals #physiological SOCIAL MEDIA PROFILESLinkedin: View original content: SOURCE Mindset Medical, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
Mindset Medical Announces FDA Clearance for its Contactless Respiratory Rate Measurement Device
PHOENIX, June 4, 2025 /PRNewswire/ -- Mindset Medical, Inc. ("Mindset Medical" or the "Company"), a digital health company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest contactless vital sign monitoring solution. The Informed Vital Core (IVC) App is a software-only medical device that measures respiratory rate through smartphones, tablets, or laptop cameras. This milestone marks Mindset Medical's second FDA clearance in less than a year, building on the success of its previously cleared pulse rate measurement device on November 18, 2024. With these clearances, Mindset Medical is closer to transforming the delivery of care with innovative telehealth technology. Mindset Medical can now offer another solution for healthcare providers to gather physiological information from their patients without needing physical contact or dedicated hardware. Software on phones, tablets, and laptops can easily be deployed in clinical and outpatient facilities, remote care environments, long-term care settings, or the patient's home. Telemedicine skyrocketed due to COVID-19, as many barriers to adoption were removed, allowing video conferencing to become routine. "Video alone is not enough. Patients and providers deserve virtual services with fewer barriers and limitations because we are all patients at the end of the day. The next step is purpose-built virtual health offerings that can legitimately provide brick-and-mortar experiences. Virtual healthcare remains a permanent fixture moving forward, and we have only scratched the surface of how we use technology to address shortcomings with the health system."-- Mitch Foster, Chairman and CEO of Mindset Medical. Mindset Medical envisions a future where vital signs and diagnoses can be captured with nothing more than everyday devices. This will help bridge gaps in access to healthcare, reduce the burden on providers, and improve chances for earlier intervention. The company continues developing its platform to include additional vital sign measurements, working closely with clinicians and patients to ensure each new feature meets their needs. About Mindset Medical Mindset Medical, Inc. ( headquartered in Phoenix, AZ, was formed by several members of Excelsius Surgical, a robotic surgical platform. Recently, Mindset Medical has developed proprietary signal-processing algorithms that extract health measurements from video. Combined with AI technology for advanced image analysis and facial recognition, these algorithms transform patients' smartphones into contactless vital sign measurement devices. Mindset Medical utilizes secure and encrypted links delivered to patients from healthcare providers to collect up-to-the-minute patient data and accurate remote physiological measurements. Contact For media, sales, or investor inquiries, please email 396163@ or 396163@ We can also be reached at 480.269.0859. HASHTAGS#healthcare #telehealth #healthequity #vitals #physiological SOCIAL MEDIA PROFILESLinkedin: View original content: SOURCE Mindset Medical, Inc. Sign in to access your portfolio
Yahoo
02-06-2025
- General
- Yahoo
10-Year-Old College Grad Breaks a Record Set by Her 2 Older Siblings, 12 and 13
Zora Elling, 10, has become the youngest person to graduate from Irvine Valley College in California, according to the school The pre-teen broke the record previously set by her own siblings, Athena and Tycho, at the same school Zora told KABC-TV that getting her record-setting degree was 'a bit scary' but also 'really fun'A 10-year-old girl is now the youngest graduate ever at a California college, breaking her own siblings' records. Zora Elling has set the record at Irvine Valley College (IVC) after receiving her Associate in Science for Transfer degree in Mathematics, according to a Facebook post shared by the school. IVC described Zora as 'a math whiz, a STEM advocate and a total inspiration.' She plans to attend the University of California in Irvine this fall. 'The Elling family continues to redefine what's possible—one remarkable milestone at a time. 💙💛,' school officials wrote. Zora said getting her record-setting degree was 'a bit scary' but also 'really fun,' according to ABC affiliate KABC-TV. "I don't really care about breaking the record, I just wanted to take the math classes," the 10-year-old explained. Zora, who has yet to graduate from high school, will transfer to UC Irvine, where she plans to major in math, this fall, according to The Orange County Register. Christina Chow, Zora's mom, said her 10-year-old daughter has long been resilient. 'As parents, you always just try to figure out what it is they like and support them,' she explained. 'For Zora, it's always been pets and reading and math.' This is the third straight year that the record has been broken, having been previously set by Zora's siblings Athena and Tycho. Athena was just 11 years old when she set the last record in May 2024, earning an associate's degree in liberal arts. Older brother Tycho was also 11 when he set the record in 2023. His birthday took place within days of his graduation, while Athena's was seven months away. Athena is currently taking more classes at IVC, while Tycho is preparing to graduate from UC Irvine this month with a bachelor's in mathematics, according to KABC-TV. Tycho reportedly plans to enter the University of Southern California's Ph.D. program in August. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Athena said she and her siblings are not fond of the phrase 'genius' being used to describe them. "I think we sort of have this rule that whatever we do, we really do it to our full extent," she said, per KABC-TV. Read the original article on People
Yahoo
25-02-2025
- Health
- Yahoo
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment
NAYA Sees Potential Positive Impact to Its Existing Fertility Operations and FDA-Cleared INVOcell Technology SARASOTA, Fla. and MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. ('NAYA') (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health, and a leading provider of in vitro fertilization (IVF) and in vivo Intravaginal Culture ('IVC') fertility treatments, proudly supports the U.S. President's recent executive order aimed at reducing the cost of IVF and expanding access to fertility services. The order directs the Domestic Policy Council to develop policy recommendations within 90 days to protect IVF access and significantly lower out-of-pocket expenses and health plan costs for families dealing with infertility. For many individuals and couples struggling with infertility, the high cost of IVF often makes treatment financially out of reach. The lack of comprehensive insurance coverage for fertility services in most states further compounds this challenge, forcing many patients to take on significant debt or forego treatment altogether. 'Infertility is a challenging medical condition, and no one should have to choose between financial stability and starting a family,' said Steve Shum, CEO of NAYA Biosciences. 'President Trump's executive order is a critical step in the right direction, and we stand ready to support efforts that make fertility treatments more accessible and affordable for all. In addition to our existing fertility clinic operations, we also believe our FDA-cleared INVOcell device and the IVC treatment process is uniquely positioned to offer an efficient, effective, and more affordable treatment solution, which is aligned with the administration's efforts to reduce costs.' Currently, fewer than 20 states mandate some level of fertility coverage, leaving millions without insurance assistance. By addressing cost concerns, the administration's action has the potential to bring hope to those who have faced heartbreaking obstacles on their journey to parenthood. 'As a trusted partner in fertility care with centers in Wisconsin, Alabama, and Georgia, NAYA remains committed to providing high-quality, patient-centered treatment and advocating for policies that support individuals and families seeking to conceive. We look forward to working alongside policymakers, medical professionals, and advocacy groups to ensure that every hopeful parent has the opportunity to experience the joy of building a family,' Shum concluded. About NAYA Women's HealthNAYA Women's Health is currently focused within the fertility marketplace. Our commercial strategy includes operating fertility-focused clinics providing treatment to patients via INVO Centers, LLC, our wholly owned subsidiary. We currently have two operational INVO Centers in the United States along with a conventional IVF clinic. Naya Women's Health also includes the INVOcell medical device. The INVOcell is the first in vivo Intravaginal Culture ('IVC') system granted FDA clearance in the United States. We believe this novel device and procedure provides a more natural, safe, effective and economical fertility treatment for patients. Unlike conventional infertility treatments such as IVF where the eggs and sperm develop into embryos in a laboratory incubator, the INVOcell utilizes the women's vagina as an incubator to support a more natural fertilization and embryo development environment, and infertility treatment. We currently sell and distribute INVOcell into existing independently owned and operated fertility clinics as well as within our own INVO Center clinics. About NAYA BiosciencesNAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health. Our proven hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets and allowing for optimized return on investment by combining scalable, profitable commercial revenues with the upside of innovative clinical-stage therapeutics. NAYA's expanding portfolio of assets currently includes NY-303, a GPC3 x NKp46 bifunctional antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase 1/2a monotherapy trial in 2025, NY-338, a CD38 x NKp46 bifunctional antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, NY-500, a PD-1 x VEGF bifunctional antibody for the treatment of HCC and other solid tumors, and NY-600 a PSMA x NKp46 bifunctional antibody for the treatment of metastatic Castration Resistant Prostate Cancer (mCRPC). Safe Harbor StatementThis release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company invokes the protections of the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as 'anticipate,' 'if,' 'believe,' 'plan,' 'estimate,' 'expect,' 'intend,' 'may,' 'could,' 'should,' 'will,' and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties, and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings at We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise. NAYA Investor & Media ContactAnna Baran-DjokovicSVP, Investor Relations+1-305-615-9162anna@ in to access your portfolio
